$ETST “We will be well prepared for that new market. We will manufacture and start to distribute our 3 new CBD-based nutraceutical products in USA in 2018 and in 2019, following our application to get a license to work with schedule II controlled substances,” said Mr. Levy, “We will develop new products with a mix of CBD and THC-rich cannabis oil. In Canada there will be a huge amount of production of dried cannabis herb, and we will profit from purchasing and transforming the excess stock these companies create.”